Alpa Laboratories Intrinsic Value
Alpa Laboratories intrinsic value. Alpa Laboratories (ALPA) median intrinsic value is ₹43.74 from 8 valuation models (range ₹18–₹147), vs current price ₹58.73 — -25.5% downside (Trading Above Calculated Value), margin of safety -34.3%. For current market price and key ratios, visit Alpa Laboratories share price today.
ALPA Valuation Methods Summary — DCF, Graham Number & P/E
Alpa Laboratories intrinsic value across 8 models vs current price ₹58.73 — upside/downside and value range per method. Read ALPA dividend track record for the complete payout history and dividend yield track record.
| Method | Type | Intrinsic Value | Range | Upside/Downside | Details |
|---|---|---|---|---|---|
| P/E Based Valuation | earnings | ₹21.12 | ₹16.90 - ₹25.34 | -64.0% | EPS: ₹0.96, Sector P/E: 22x |
| Book Value Method | asset | ₹146.82 | ₹132.14 - ₹161.50 | +150.0% | Book Value/Share: ₹88.57, P/B: 2.0x |
| Revenue Multiple Method | revenue | ₹117.46 | ₹105.71 - ₹129.21 | +100.0% | Revenue/Share: ₹59.05, P/S: 2.0x |
| EBITDA Multiple Method | earnings | ₹57.14 | ₹51.43 - ₹62.85 | -2.7% | EBITDA: ₹12.00Cr, EV/EBITDA: 10x |
| Simple DCF (5Y) | dcf | ₹39.79 | ₹31.83 - ₹47.75 | -32.2% | CF Growth: 5.0%, Discount: 15% |
| PEG Ratio Method | growth | ₹17.62 | ₹15.86 - ₹19.38 | -70.0% | EPS Growth: 8.0%, Fair P/E: 6.4x |
| Growth Adjusted P/E | growth | ₹17.62 | ₹15.86 - ₹19.38 | -70.0% | Revenue Growth: 6.0%, Adj P/E: 15.5x |
| Graham Defensive Method | conservative | ₹43.74 | ₹39.37 - ₹48.11 | -25.5% | EPS: ₹0.96, BVPS: ₹88.57 |
ALPA Intrinsic Value vs Market Price — All Valuation Models
Alpa Laboratories fair value range ₹18–₹147 vs current market price ₹58.73 across 8 valuation models. Compare with Alpa Laboratories valuation methods to assess whether the stock is under or overvalued.
ALPA Intrinsic Value Analysis — Undervalued or Overvalued?
Alpa Laboratories median intrinsic value ₹43.74, current price ₹58.73 — Trading Above Calculated Value by 25.5%, margin of safety -34.3%.
What is the intrinsic value of ALPA?
Based on our comprehensive analysis using 8 different valuation methods, the estimated intrinsic value of Alpa Laboratories (ALPA) is ₹43.74 (median value). With the current market price of ₹58.73, this represents a -25.5% variance from our estimated fair value.
The valuation range spans from ₹17.62 to ₹146.82, indicating ₹17.62 - ₹146.82.
Is ALPA undervalued or overvalued?
Based on our multi-method analysis, Alpa Laboratories (ALPA) appears to be trading above calculated value by approximately 25.5%.
ALPA Financial Health — Key Ratios vs Industry Benchmarks
Alpa Laboratories financial ratios — ROE, debt-to-equity, profit margins and liquidity vs industry benchmarks and their impact on intrinsic value.
| Financial Metric | Current Value | Industry Benchmark | Assessment | Impact on Valuation |
|---|---|---|---|---|
| Current Ratio | 70.33 | Industry Standard: 2.0+ | Above 2.0 | Measures short-term liquidity capacity |
| Return on Equity | 2.2% | Industry Standard: 15%+ | Below 10% | Measures shareholder return efficiency |
| Operating Margin | 11.0% | Industry Standard: 20%+ | Above 10% | Indicates operational efficiency level |
| Asset Turnover Ratio | 0.51x | Industry Standard: 1.0x+ | Above 0.5x | Measures asset utilization efficiency |
ALPA Cash Flow Quality — Operating & Free Cash Flow
Alpa Laboratories operating cash flow, free cash flow, quality rating and sustainability score by period — key inputs to DCF intrinsic value calculation.
| Period | Operating Cash Flow | Free Cash Flow | Cash Flow Quality | Sustainability Score |
|---|---|---|---|---|
| March 2026 | ₹9 Cr | ₹4 Cr | Positive Free Cash Flow | 7/10 |
| March 2025 | ₹18 Cr | ₹12 Cr | Positive Free Cash Flow | 8/10 |
| March 2024 | ₹4 Cr | ₹-3 Cr | Positive Operating Cash Flow | 6/10 |
| March 2023 | ₹9 Cr | ₹9 Cr | Positive Free Cash Flow | 8/10 |
| March 2022 | ₹10 Cr | ₹2 Cr | Positive Free Cash Flow | 7/10 |